Tazorac and Intestinal obstruction - a phase IV clinical study of FDA data

Summary:

Intestinal obstruction is reported as a side effect among people who take Tazorac (tazarotene), especially for people who are male, 10-19 old, also take Accutane, and have Acne cystic.

The phase IV clinical study analyzes which people have Intestinal obstruction when taking Tazorac. It is created by eHealthMe based on reports of 1,001 people who have side effects when taking Tazorac from the FDA, and is updated regularly.

What is Tazorac?

Tazorac has active ingredients of tazarotene. It is often used in acne. eHealthMe is studying from 1,046 Tazorac users. Check the latest studies of Tazorac.

What is Intestinal obstruction?

Intestinal obstruction is found to be associated with 1,884 drugs and 2,619 conditions by eHealthMe. Check the latest studies of Intestinal obstruction.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

1,001 people reported to have side effects when taking Tazorac.
Among them, 12 people (1.2%) have Intestinal obstruction.

Could Tazorac cause Intestinal obstruction?

Among these 12 people:

What is the gender of people who have Intestinal obstruction when taking Tazorac? *

female: 25 %
male: 75 %

What is the age of people who have Intestinal obstruction when taking Tazorac? *

What are other drugs people take besides Tazorac? *

What are other side effects people have besides Intestinal obstruction? *

Inflammatory Bowel Disease: 9 people, 75.00%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 8 people, 66.67%
Depression: 8 people, 66.67%
High Blood Cholesterol: 8 people, 66.67%
Hypertrophic Anal Papilla (benign growths of connective tissue that are covered by squamous cells): 7 people, 58.33%
Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking): 7 people, 58.33%
Arthropathy: 7 people, 58.33%
Clostridium Difficile Colitis (inflammation of colon by clostridium difficile bacteria infection): 7 people, 58.33%
Lip Dry: 7 people, 58.33%
Anaemia (lack of blood): 7 people, 58.33%

What are the existing conditions these people have? *

Acne Cystic (skin problems that cause pimples): 5 people, 41.67%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 1 person, 8.33%
Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 1 person, 8.33%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 8.33%
Joint Pain: 1 person, 8.33%
Hypersensitivity: 1 person, 8.33%
High Blood Pressure: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Tazorac and have Intestinal obstruction?

- Check whether Intestinal obstruction is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tazorac:

Tazorac (1,046 reports)

Browse all side effects of Tazorac:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Intestinal obstruction:

Intestinal obstruction (1,884 drugs)

Browse all the conditions that are associated with Intestinal obstruction:

Intestinal obstruction (2,619 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on tazarotene (the active ingredients of Tazorac) and Tazorac (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.